Home/Filings/4/0001104659-22-100803
4//SEC Filing

Berrey M Michelle 4

Accession 0001104659-22-100803

CIK 0001270073other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 4:02 PM ET

Size

4.9 KB

Accession

0001104659-22-100803

Insider Transaction Report

Form 4
Period: 2022-09-14
Berrey M Michelle
President, R&D and CMO
Transactions
  • Tax Payment

    Common Stock

    2022-09-14$17.14/sh1,246$21,35671,188 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1
  • filerCIK 0001397329

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:02 PM ET
Size
4.9 KB